Template:Prenatal Diagnosis terms: Difference between revisions

From Embryology
mNo edit summary
Line 1: Line 1:
==Prenatal Diagnosis Terms==
 
[[Prenatal Diagnosis|'''Prenatal Diagnosis Terms''']]
* '''cell-free fetal deoxyribonucleic acid''' - (cffDNA) refers to fetal DNA circulating and isolated from the plasma portion of maternal blood.
* '''cell-free fetal deoxyribonucleic acid''' - (cffDNA) refers to fetal DNA circulating and isolated from the plasma portion of maternal blood.
* '''false negative rate''' - The proportion of pregnancies that will test negative given that the congenital anomaly is present.
* '''false negative rate''' - The proportion of pregnancies that will test negative given that the congenital anomaly is present.

Revision as of 11:41, 15 June 2016

Prenatal Diagnosis Terms

  • cell-free fetal deoxyribonucleic acid - (cffDNA) refers to fetal DNA circulating and isolated from the plasma portion of maternal blood.
  • false negative rate - The proportion of pregnancies that will test negative given that the congenital anomaly is present.
  • false positive rate - The proportion of pregnancies that will test positive given that the congenital anomaly is absent.
  • negative predictive value - The probability that a congenital anomaly is absent given that the prenatal screening test is negative.
  • Non-Invasive Prenatal Testing - (NIPT) could refer to ultrasound or other imaging techniques, but more frequently used to describe analysis of cell-free fetal DNA circulating in maternal blood.
  • positive predictive value - The probability that a congenital anomaly is present given that the prenatal screening test is positive.
  • pre-implantation genetic diagnosis - (PGD, pre-implantation genetic screening) a diagnostic procedure for embryos produced through Assisted Reproductive Technology (ART or in vitro fertilisation, IVF) for genetic diseases that would generate developmental abnormalities or serious postnatal diseases.
  • prenatal screening sensitivity - (detection rate) The probability of testing positive on a prenatal screening test if the congenital anomaly is present.
  • prenatal screening specificity - The probability of testing negative on a prenatal screening test if the congenital anomaly is absent.
  • single nucleotide polymorphisms - (SNPs) the variation in a single DNA nucleotide that occurs at a specific position in the genome.